Fetal hemoglobin glycation may reflect hyperglycemia in utero

July 21, 2014
Fetal hemoglobin glycation may reflect hyperglycemia in utero

(HealthDay)—Glycation of the α-chain (Glα) in fetal hemoglobin is higher in neonates from women with gestational diabetes mellitus and may reflect hyperglycemia exposure in utero, according to a study published online July 10 in Diabetes Care.

Felix O. Dupont, from the Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke in Canada, and colleagues conducted a case-control study involving 37 women with and 30 pregnant women with normal glucose tolerance. They measured the percentage of glycated hemoglobin in cord blood using a unique mass spectrometry method.

The researchers found that in neonates from women with gestational diabetes mellitus, Glα was higher (2.32 versus 2.20 percent; P < 0.01). In the overall cohort, and in each group, Glα correlated with maternal hemoglobin A1c measured at delivery (overall cohort: r = 0.67; P < 0.0001; mellitus group: r = 0.66; P < 0.0001: normal glucose tolerance group: r = 0.50; P = 0.01).

"Thus, Glα may reflect hyperglycemic exposure during the last weeks of fetal development," the authors write. "Future studies will confirm Glα is a predictive biomarker of prenatally programmed lifetime metabolic health and disease."

Explore further: Sleep-disordered breathing may affect pregnancy outcomes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Neonatal size unaffected by gestational diabetes drugs

March 8, 2013

(HealthDay)—Women with gestational diabetes mellitus treated with metformin or insulin have similar changes in markers of metabolic status and no differences in offspring birth weight, according to a study published in ...

Hemoglobin A1C inadequate for postpartum diabetes screening

June 19, 2012

(HealthDay) -- For postpartum women who have had gestational diabetes mellitus (GDM), the hemoglobin A1c (A1C) test criteria alone or in combination with fasting glucose test criteria does not provide sensitive and specific ...

Recommended for you

New blood test may better predict gestational diabetes

April 27, 2017

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity ...

Post-biotics may help shield obese from diabetes

April 20, 2017

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.